Goethe University
Clinical trials sponsored by Goethe University, explained in plain language.
-
New combo therapy offers hope for older leukemia patients
Disease control CompletedThis study tested a new treatment approach for adults over 55 with a specific type of leukemia (B-precursor ALL). The goal was to see if using a targeted drug called blinatumomab along with a reduced dose of chemotherapy could help patients achieve remission with fewer side effec…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
Tailored therapy boosts survival in adult blood cancer patients
Disease control CompletedThis study tested a personalized, intensive treatment plan for over 1,000 adults newly diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. The approach used strong chemotherapy based on pediatric regimens, targeted drugs, and stem cell transplants when ne…
Phase: PHASE3 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New drug combo shows promise for rare kidney cancer
Disease control CompletedThis study tested a combination of two immunotherapy drugs (nivolumab and ipilimumab) against standard treatments for people with a rare type of advanced kidney cancer called non-clear cell renal cell carcinoma. About 316 participants who had not received prior treatment took par…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC